Lotecan Eye Drop contains Loteprednol etabonate 0.2% w/v, a corticosteroid indicated for the treatment of ocular inflammation and pain associated with various ophthalmic conditions such as allergic conjunctivitis, postoperative inflammation, and anterior uveitis. Loteprednol etabonate is a corticosteroid with potent anti-inflammatory properties that works by inhibiting the release of inflammatory mediators and suppressing leukocyte infiltration in ocular tissues. The formulation is designed for topical ocular administration, providing targeted relief while minimizing systemic absorption. Lotecan Eye Drop is typically prescribed for short-term use to reduce inflammation, edema, and discomfort in the eye. It is essential to use this medication under strict medical supervision, as prolonged use or misuse may lead to adverse effects such as increased intraocular pressure, glaucoma, cataract formation, or secondary ocular infections. Patients should be advised to avoid contact lens use during treatment unless otherwise directed by a healthcare professional. Before initiating therapy, a thorough ophthalmic examination is recommended to rule out viral, fungal, or mycobacterial infections, which may be exacerbated by corticosteroid use. Lotecan Eye Drop should be stored at room temperature, protected from light, and kept out of reach of children. Adherence to prescribed dosage and duration is critical to ensure efficacy and safety.